General Information
Drug ID
DR00007
Drug Name
Prostaglandin f2Alpha
Synonyms
Amoglandin; Cerviprost; Cyclosin; Enzaprost; PGF2alpha; Panacelan
Drug Type
Small molecular drug
Indication Solid tumours [ICD11: 2D4Z] Preclinical [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5280363"></iframe>
3D MOL 2D MOL
Formula
C20H34O5
Canonical SMILES
CCCCCC(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O
InChI
InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1
InChIKey
PXGPLTODNUVGFL-YNNPMVKQSA-N
CAS Number
CAS 551-11-1
Pharmaceutical Properties Molecular Weight 354.487 Topological Polar Surface Area 98
Heavy Atom Count 25 Rotatable Bond Count 12
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 5
XLogP
2.7
PubChem CID
5280363
PubChem SID
103214323 , 103943633 , 104046437 , 113853160 , 124892254 , 124892255 , 125307573 , 126662422 , 134340899 , 134978425 , 135651540 , 137006907 , 142063920 , 144205330 , 14852168 , 15398784 , 162205063 , 175268163 , 175607780 , 176484109 , 179116866 , 211534905 , 223673680 , 226412676 , 26754609 , 29216066 , 3912 , 39289529 , 4265953 , 47588758 , 47588759 , 48258963 , 48415906 , 50026801 , 50110092 , 53789218 , 56311306 , 56313004 , 56313208 , 57357710 , 613198 , 77668180 , 7847149 , 7980284 , 8143215 , 8616237 , 92308787 , 92309910 , 99300824 , 99302342
ChEBI ID
CHEBI:15553
TTD Drug ID
D00HTY
DT(s) Transporting This Drug MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [2]
OAT1 Transporter Info Organic anion transporter 1 Substrate [3]
OAT2 Transporter Info Organic anion transporter 2 Substrate [4]
OAT3 Transporter Info Organic anion transporter 3 Substrate [3]
OAT4 Transporter Info Organic anion transporter 4 Substrate [3]
OATP2A1 Transporter Info Organic anion transporting polypeptide 2A1 Substrate [5]
OATP3A1 Transporter Info Organic anion transporting polypeptide 3A1 Substrate [6]
OCT1 Transporter Info Organic cation transporter 1 Substrate [3]
OCT2 Transporter Info Organic cation transporter 2 Substrate [3]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OAT1 Transporter Info Km = 0.575 microM Proximal tubule (S2) cells-OAT1 [3]
OAT2 Transporter Info Km = 0.425 microM Proximal tubule (S2) cells-OAT2 [4]
OAT3 Transporter Info Km = 1.092 microM Proximal tubule (S2) cells-OAT3 [3]
OAT4 Transporter Info Km = 0.692 microM Proximal tubule (S2) cells-OAT4 [3]
OCT1 Transporter Info Km = 0.477 microM Proximal tubule (S2) cells-OCT1 [3]
OCT2 Transporter Info Km = 0.344 microM Proximal tubule (S2) cells-OCT2 [3]
References
1 Stereocontrolled organocatalytic synthesis of prostaglandin PGF2alpha in seven steps. Nature. 2012 Sep 13;489(7415):278-81.
2 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
3 Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. J Pharmacol Exp Ther. 2002 Apr;301(1):293-8.
4 Interaction of human organic anion transporters 2 and 4 with organic anion transport inhibitors. J Pharmacol Exp Ther. 2002 Jun;301(3):797-802.
5 Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest. 1996 Sep 1;98(5):1142-9.
6 Molecular characterization of human and rat organic anion transporter OATP-D. Am J Physiol Renal Physiol. 2003 Dec;285(6):F1188-97.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.